These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1372467)

  • 1. A rise of erythrocytes and platelets in a patient with myelodysplastic syndrome during the administration of G-CSF.
    Washizuka T; Koike T; Toba K; Nagai K; Takahashi M; Shibata A
    Am J Hematol; 1992 Feb; 39(2):153-4. PubMed ID: 1372467
    [No Abstract]   [Full Text] [Related]  

  • 2. Trilineage response to recombinant human granulocyte colony-stimulating factor administration in a patient with myelodysplastic syndrome.
    Rey C; Bader-Meunier B; Tertian G; Mielot F; Tchernia G; Yver A
    Am J Hematol; 1993 May; 43(1):76-7. PubMed ID: 7686335
    [No Abstract]   [Full Text] [Related]  

  • 3. Trilineage response to granulocyte colony-stimulating factor administration in a patient with myelodysplastic syndrome.
    Perugini O; Montanari G; Nalli G
    Haematologica; 1995; 80(3):234-7. PubMed ID: 7545637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial.
    Negrin RS; Haeuber DH; Nagler A; Olds LC; Donlon T; Souza LM; Greenberg PL
    Ann Intern Med; 1989 Jun; 110(12):976-84. PubMed ID: 2471429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes.
    Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Furusawa S; Miura Y; Takaku F; Saito M
    Clin Exp Immunol; 1993 Feb; 91(2):308-13. PubMed ID: 7679062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin.
    Mantovani L; Lentini G; Hentschel B; Wickramanayake PD; Loeffler M; Diehl V; Tesch H
    Br J Haematol; 2000 May; 109(2):367-75. PubMed ID: 10848827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hematological effect of 14 days treatment of recombinant human granulocyte colony-stimulating factor for neutropenia in myelodysplastic syndromes].
    Yoshida Y; Hirashima K; Asano S; Takaku F; Furusawa S; Ogawa T; Arimori S; Abe T; Suzuki T; Kato Y
    Rinsho Ketsueki; 1991 Jul; 32(7):743-50. PubMed ID: 1717726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early trilineage recovery by granulocyte colony-stimulating factor in a patient with aplastic anemia.
    Hashimoto K; Kanakura Y; Yagura H; Mitsui H; Ogawa M; Horikawa Y; Nishiura T; Kanayama Y; Matsuzawa Y
    Acta Haematol; 1995; 93(2-4):110-2. PubMed ID: 7543718
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of anemia in myelodysplastic syndrome with darbepoetin and granulocyte colony stimulating factor.
    Rose S; Ali Y; Maffei B; Saidi P
    Am J Hematol; 2007 Mar; 82(3):245-6. PubMed ID: 16924646
    [No Abstract]   [Full Text] [Related]  

  • 10. Predicting erythroid response to recombinant erythropoietin plus granulocyte colony-stimulating factor therapy following a single subcutaneous bolus in patients with myelodysplasia.
    Bowen D; Hyslop A; Keenan N; Groves M; Culligan D; Johnson P; Shaw A; Geddes F; Evans P; Porter J; Cavill I
    Haematologica; 2006 May; 91(5):709-10. PubMed ID: 16670077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of recombinant human granulocyte-macrophage colony stimulating factor on hematopoiesis in normal cynomolgus monkeys.
    Aramaki K; Yanagida M; Kikumori M; Kojima M; Suzuki T; Amano K
    J Vet Med Sci; 1993 Apr; 55(2):221-5. PubMed ID: 7685638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphologic changes of neutrophils in myelodysplastic syndrome treated with recombinant human granulocyte colony-stimulating factor.
    Toyama K; Ohyashiki K; Ohyashiki JH; Takaku F
    Jpn J Cancer Res; 1988 Jul; 79(7):813-6. PubMed ID: 2459090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous and cytokine-induced thrombocytopenia in myelodysplastic syndromes: serum thrombopoietin levels and bone marrow morphology. Scandinavian MDS Group, Sweden and Norway.
    Hellström-Lindberg E; Kanter-Lewensohn L; Nichol J; Ost A
    Br J Haematol; 1999 Jun; 105(4):966-73. PubMed ID: 10554808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of recombinant human G-CSF combined with EPO in treatment of patients with MDS].
    Li ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):512-3. PubMed ID: 15972155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
    Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
    J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of cytarabine ocfosfate on colony-stimulating factor in myelodysplastic syndrome with monosomy 7].
    Masumoto A; Ohbayashi Y; Kawada H; Arimori K; Sasao T; Ogawa Y; Fujiwara H; Fukuda R; Watanabe S; Umeda Y
    Rinsho Ketsueki; 1994 Jun; 35(6):603-8. PubMed ID: 7521405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amifostine in combination with erythropoietin and G-CSF promotes multilineage hematopoiesis in patients with myelodysplastic syndrome.
    Neumeister P; Jaeger G; Eibl M; Sormann S; Zinke W; Linkesch W
    Leuk Lymphoma; 2001 Jan; 40(3-4):345-9. PubMed ID: 11426556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial.
    Vannucchi AM; Bosi A; Ieri A; Guidi S; Saccardi R; Lombardini L; Linari S; Laszlo D; Longo G; Rossi-Ferrini P
    Bone Marrow Transplant; 1996 Apr; 17(4):527-31. PubMed ID: 8722349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.